Ooops

Two Questions for Jarden's 2008 Year End

How's that short workin for ya?? OUCH!

TransDigm: Issuing Debt for Dividends?

umm, with 50+% EBITDA MARGINS i would think they can handle the debt load

Cenveo Amending Its Credit Facility

Nice pic brah! How do you manage time to do work on stocks with all your boarding dude!!

Analyst Estimates for Jarden in 2009 Look Ridiculously Optimistic

what does your net debt to ebitda calc look like when you factor in the cash flow the company will generate over the next 4-5 qtrs? you made no mention of how much cash the company should generate nor gave them any credit for it in your thesis above.

BioScrip Investors Would Welcome a Strategic Buyer

The reason why he said no comment is because nobody wants to buy this company (except Amit), they went through a strategic sale review a few years ago and nobody was interested. Amit I am surprised that you are long this stock and short JAH, should have played the opposite as BIOS has been a disaster and JAH has delivered good results (prob. why the stock is up 25% in 3 months). Better luck next time.

Jarden's 'Rope a Dope' Investor Relations

I anxiously await your next garbage piece after JAH delivered a strong quarter and excellent cash flow. Cash is cash and no matter what you claim that is the ultimate measure of performance. Bucket shops?? Since when were Lehman and Goldman considered bucket shops?
I find it amazing you are allowed to publish slanted pieces like this when you are short the stock as your only aim is to benefit yourself and your investment by being negative (more like tabloid journalism).
We see right through you.